Lynx Dx Launches At-Home Prostate Cancer Test
Lynx Dx announced at-home availability of a urine-based prostate cancer test that eliminates the need for a digital rectal exam.
Read MorePosted by Andy Lundin | Feb 3, 2025 | Prostate |
Lynx Dx announced at-home availability of a urine-based prostate cancer test that eliminates the need for a digital rectal exam.
Read MorePosted by Andy Lundin | Jan 29, 2025 | Prostate, Urinalysis & Toxicology |
A new study validated a urine test that offers a less invasive, more accurate alternative to traditional prostate cancer screening.
Read MorePosted by Andy Lundin | Jan 22, 2025 | Unknown Origin & Other Cancer Types |
A biomarker-based algorithm combined with a noninvasive test identifies those at risk for esophageal cancer or precancerous conditions.
Read MorePosted by Andy Lundin | Jan 21, 2025 | Prostate |
A review found gaps remain for genomic classifier tests for their cost-effectiveness, clinical utility, and impact on diverse populations.
Read MorePosted by Andy Lundin | Jan 9, 2025 | Cancer, Molecular Diagnostics |
Summary: A Mayo Clinic-led international study utilized CRISPR-Cas9 technology to classify 91% of...
Read More